Mutual Recognition Procedure for the Registration of Medicines: New Challenges or Opportunities

Introduction. An important task for pharmaceutical manufacturers is to bring high quality, effective and safe medicines to the market. In the event that the country's resources are not enough, drugs that have been successfully registered in other countries come to the rescue.

Aim. To study the possibilities and advantages of the procedure of mutual recognition of registration medicinal products as a potential for the development of domestic producers.

Materials and methods. The materials of the study were available publications in peer-reviewed journals on thematic queries based on keywords of the selected topic, official websites, regulatory legal acts, regulating the procedure for registering medicinal products in the EU and the Russian Federation.

Results and discussion. New approaches to registration within the framework of the Eurasian Economic Union (using the example of the mutual recognition procedure) are considered from the perspective of new opportunities and emerging problems for domestic manufacturers of generic drugs. A comparative analysis of the mutual recognition procedure and the national procedure for registration of medicinal products revealed a number of advantages for domestic manufacturers, favoring the introduction of medicinal products into circulation on the territory of the EAEU.

Conclusion. The review of the process of harmonization of the registration practice of medicinal products in the EAEU speaks of the prospects of using the mutual recognition procedure for developing the potential of domestic manufacturers and facilitating access to effective and safe drugs.

1. Regulating pharmaceuticals in Europe. Available at: https://www.euro.who.int/ Accessed: 14.09.2021.

2. Direktiva 2001/83/ES Evropeyskogo parlamenta i Soveta ES ot 6.11.2001 "O svode zakonov Soobshchestva v otnoshenii lekarstvennykh preparatov dlya cheloveka" [Directive 2001/83/EC of the European Parliament and of the Council of 6 Novemder 2001 on the Community code relating to medicinal products for the human use]. (In Russ.)

3. Reglament (EC) № 726/2004 Evropeyskogo parlamenta i Soveta ot 31 marta 2004 g., ustanavlivayushchiy soyuznye protsedury razresheniya i nadzora dlya lekarstvennykh preparatov dlya meditsinskogo i veterinarnogo primeneniya i uchrezhdayushchiy Evropeyskoe agentstvo po lekarstvam [Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency]. Available at: https://base.garant.ru/2570581/ Accessed: 05.05.2021. (In Russ.)

4. EMA. Available at: https://www.ema.europa.eu/ Accessed: 05.05.2021.

5. Federal'nyy zakon ot 12.04.2010 g. № 61-FZ "Ob obrashchenii lekarstvennykh sredstv" [Federal Law No. 61-FZ of 12.04.2010 "On the Circulation of Medicines"]. Available at: https://base.garant.ru/12174909/ Accessed: 05.05.2021. (In Russ.)

6. Zakon Respubliki Belarus' ot 20 iyulya 2006 g. № 161-Z "O lekarstvennykh sredstvakh" [Law of the Republic of Belarus dated July 20, 2006 No. 161-З "On Medicines"]. Available at: https://belzakon.net/Zakonodatelstvo/Zakon_RB/2006/794. Accessed: 05.05.2021. (In Russ.)

7. Kodeks Respubliki Kazakhstan ot 7 iyulya 2020 g. № 360-VI "O zdorov'e naroda i sisteme zdravookhraneniya" [Code of the Republic of Kazakhstan dated July 7, 2020 No. 360-VI "On people’s health and the health care system"]. Available at: https://kodeksy-kz.com/ka/o_zdorove_naroda_i_sisteme_zdravoohraneniya.htm. Accessed: 05.05.2021. (In Russ.)

8. Zakon Respubliki Armeniya ot 13 iyunya 2016 g. № ZR-86 "O lekarstvennykh sredstvakh" [Law of the Republic of Armenia dated June 13, 2016 No. ЗР-86 "On Medicines"]. Available at: https://base.spinform.ru/show_doc.fwx?rgn=89529. Accessed: 05.05.2021. (In Russ.)

9. Zakon Kyrgyzskoy Respubliki ot 2 avgusta 2017 g. № 165 "Ob obrashchenii lekarstvennykh sredstv" [Law of the Kyrgyz Republic dated August 2, 2017 No. 165 "On the Circulation of Medicines"]. Available at: http://cbd.minjust.gov.kg/act/view/ru-ru/111672. Accessed: 05.05.2021. (In Russ.)

10. Soglashenie o edinykh printsipakh i pravilakh obrashcheniya lekarstvennykh sredstv v ramkakh Evraziyskogo ekonomicheskogo soyuza ot 23 dekabrya 2014 g. [Agreement on common principles and rules for the circulation of medicines within the Eurasian Economic Union dated December 23, 2014]. Available at: https://docs.eaeunion.org/docs/ru-ru/0147061/itia_24122014. Accessed: 05.05.2021. (In Russ.)

11. Dogovor o Evraziyskom ekonomicheskom soyuze ot 29 maya 2014 g. [Treaty on the Eurasian Economic Union dated May 29, 2014]. Available at: https://docs.eaeunion.org/docs/ru-ru/0043610/itia_05062014. Accessed: 27.07.2021. (In Russ.)

12. Remedium ot 30.03.2020 g. [Remedium from 30.03.2020]. Available at: https://remedium.ru/ Accessed: 14.09.2021. (In Russ.)

13. Reshenie Soveta Evraziyskoy ekonomicheskoy komissii № 75 "Ob utverzhdenii Polozheniya ob Ekspertnom komitete po lekarstvennym sredstvam" ot 03.11.2016 g. [Decision of the Council of the Eurasian Economic Commission No. 75 of 03.11.2016 "On approval of the Regulation on the Expert Committee on Medicines" Available at: http://www.eurasiancommission.org/ Accessed: 24.09.2021. (In Russ.)

14. Rossiyskaya gazeta ot 09.12.2019 g. [Russian newspaper dated 09.12.2019]. Available at: https://rg.ru/ Accessed: 14.09.2021. (In Russ.)

15. Sayt Evraziyskoy ekonomicheskoy komissii [Website of the Eurasian Economic Commission]. Available at: http://www.eurasiancommission.org/ Accessed: 14.09.2021. (In Russ.)